Verizon ofrecerá toda la nueva serie de iPhone 16
September 10, 2024 19:10 ET
|
Verizon Sourcing LLC
NUEVA YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Verizon ofrecerá iPhone 16 y iPhone 16 Plus, diseñados para Apple Intelligence1 con el nuevo chip A18, control de cámara, potentes actualizaciones al...
Avis Budget Group Announces Pricing of $700 Million of Senior Notes
September 10, 2024 17:22 ET
|
Avis Budget Group, Inc.
PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis...
Aeries Technology Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
September 10, 2024 17:00 ET
|
Aeries Technology, Inc.
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries Technology” or “the Company”) (Nasdaq: AERT), a global professional services and technology consulting partner, today...
U.S. Global Investors Reports $11 Million Revenue in Fiscal 2024, Repurchasing Over $2 Million in Shares While Generating a Strong Shareholder Yield of 9.41%
September 10, 2024 16:58 ET
|
U.S. Global Investors
SAN ANTONIO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with deep expertise in global markets and...
APA Announces Agreement for $950 Million Asset Sale of Non-core Properties in the Permian Basin
September 10, 2024 16:48 ET
|
APA Corporation
HOUSTON, Sept. 10, 2024 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) announced today entry into an agreement for the sale of non-core producing properties in the Permian Basin to an undisclosed...
Weatherford Announces S&P Credit Rating Upgrade To ‘BB-’ From 'B+', Positive Outlook
September 10, 2024 16:46 ET
|
Weatherford International, LLC
HOUSTON, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced the Company’s issuer credit rating has recently been...
BridgeBio Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program
September 10, 2024 16:45 ET
|
BridgeBio Pharma, Inc.
- Receipt of RMAT Designation is based on preliminary clinical evidence from the CANaspire Phase 1/2 clinical trial, which showed functional improvements in all dosed patients indicating that BBP-812...
BridgeBio Pharma Reports Topline Results from Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)
September 10, 2024 16:45 ET
|
BridgeBio Pharma, Inc.
- Increase in endogenous cortisol production achieved in all patients in higher dose cohorts of BBP-631, a result seen for the first time ever in CAH patients - The gene therapy was well tolerated...
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 10, 2024 16:40 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2024, the Compensation Committee of Crinetics’ Board of Directors...
Eureka Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on September 12, 2024
September 10, 2024 16:35 ET
|
Eureka Acquisition Corp
Hong Kong, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Eureka Acquisition Corp (the “Company”) (Nasdaq: EURK), a blank check company, today announced that, commencing on September 12, 2024, holders of the...